All Posts: News Release
-
Majority of Older Breast Cancer Patients Use Hormone Treatment
WASHINGTON — One of the most comprehensive looks at the use of hormone therapy in women over 65 with non-metastatic breast cancer found some welcome news. Except for frail patients, most participants in the large study complied with their oncologists’ recommendations to treat their estrogen-positive breast cancer with hormone therapy — either an aromatase inhibitor or tamoxifen. These drugs prevent tumors from using estrogen to fuel growth.
Category: News Release
-
Tamoxifen Resistant Breast Cancer Reversed When Drug Paired with Anti-malaria Agent
WASHINGTON — The inexpensive anti-malarial drug hydroxychloroquine (HCQ) reverses resistance to tamoxifen, a widely used breast cancer drug, in mice.
Category: News Release
-
Media Advisory: The Men’s Event Benefitting Prostate Cancer Research
Last year, nearly 239,000 men were diagnosed with prostate cancer, and according to the American Cancer Society, about 30,000 men died from the disease. On Monday, June 23, for the 15th year, prominent Washington, DC-area businessmen will gather for The Men’s Event to support prostate cancer research happening at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Georgetown Starts Study to Halt Alzheimer’s Disease in Those at High-Risk
WASHINGTON–Georgetown University Medical Center researchers have launched a clinical study aimed at preventing or delaying Alzheimer’s disease in people who don’t have symptoms but already have the tale-tell signs in their brains.
Category: News Release
-
Resistance to Lung Cancer Targeted Therapy Can be Reversed, Study Suggests
WASHINGTON — Up to 40 percent of lung cancer patients do not respond to a targeted therapy designed to block tumor growth — a puzzling clinical setback that researchers have long tried to solve. Now, scientists at Georgetown Lombardi Comprehensive Cancer Center and the National Cancer Institute have discovered why that intrinsic resistance occurs — and they pinpoint a drug they say could potentially reverse it.
Category: News Release
-
Cancer Centers Combine Expertise to Optimize Advanced Immunotherapy Strategies
WASHINGTON — Physician researchers from Georgetown Lombardi Comprehensive Cancer Center, in Washington, D.C., and John Theurer Cancer Center (JTCC) in Hackensack, New Jersey, announce today the formation of the Regional Immunotherapy Discovery Program.
Category: News Release
-
Georgetown Offers First U.S. Program for Young People Impacted by Huntington Disease
WASHINGTON (May 20, 2014) — Young people from Baltimore to Richmond impacted by Huntington Disease — a hereditary, progressively degenerative brain disorder that leads to death and has no cure — now have easy access to a broad range of support services, thanks to a pioneering international partnership spearheaded by the Huntington Disease Care, Education and Research Center at MedStar Georgetown University Hospital.
Category: News Release
-
Children of Nicotine-Addicted Parents More Likely to Become Heavy Smokers
WASHINGTON – The more time a child is exposed to a parent addicted to smoking, the more likely the youth will not only take up cigarettes but also become a heavy smoker.
Category: News Release
-
New Tool to Grow Cancer Cells Streamlines Laboratory Research
WASHINGTON – A new technique that allows the growth of both normal and cancer cells and keeps them alive indefinitely is transforming and expediting basic cancer research, say investigators from Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Georgetown Lombardi Fields Top Fundraising Team at Avon Walk in Washington
Dozens of volunteers and patients representing Capital Breast Care Center (CBCC), part of Georgetown Lombardi Comprehensive Cancer Center, took to the streets of Washington this weekend for the two-day, 39.3-mile Avon Walk for Breast Cancer. The Georgetown Lombardi/Capital Breast Care Center team is the top fund raising team this year, bringing in more than $186,000.
Category: News Release